Rare diseases
Investigational molecules
Locations
328 conditions with trials, the busiest first
865 trials across Europe, recruiting first
Study on Anifrolumab for Adults with Active Lupus Nephritis
BelgiumStudy on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy
GermanyStudy on the Effects of Baricitinib in Early-Stage Rheumatoid Arthritis
GermanyStudy of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis
BelgiumStudy on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis
AustriaStudy on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis
PortugalStudy of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials
FranceStudy on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus
FranceStudy on Pain Relief in Hip Fracture Surgery: Comparing Levobupivacaine Block with No Block for Patients Undergoing Hip and Proximal Femur Surgery
SpainStudy on Long-Term Safety and Effects of Vosoritide in Children with Achondroplasia
FranceStudy of sodium chloride solution injections (Localized Tissue Hydration) for adults with chronic low back pain
FranceStudy of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus
BulgariaThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
